Insider Trading & Ownership - Ahrens Brenton Karl

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Ahrens Brenton Karl
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2022-09-16
Sale
2022-09-20
6:00 pm
Iterum Therapeutics plcITRMAhrens Brenton Karl
Director
37,246$1.8238$67,930410
(Indirect
Direct)
View
2022-09-13
Sale
2022-09-15
5:36 pm
Iterum Therapeutics plcITRMAhrens Brenton Karl
Director
45,000$2.0855$93,84637,656
(Indirect
Direct)
View
2022-09-08
Sale
2022-09-12
9:01 pm
Iterum Therapeutics plcITRMAhrens Brenton Karl
Director
33,298$2.3065$76,80382,656
(Indirect
Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2022-12-23
Option Award
2022-12-28
9:00 pm
N/A
2032-12-22
Iterum Therapeutics plcITRMAhrens Brenton Karl
Director
29,125$0.8129,125
(Direct)
View
2022-09-25
Option Award
2022-09-28
06:12 am
N/A
2032-09-24
Iterum Therapeutics plcITRMAhrens Brenton Karl
Director
14,838$1.5914,838
(Direct)
View
2022-06-25
Option Award
2022-06-28
9:00 pm
N/A
2032-06-24
Iterum Therapeutics plcITRMAhrens Brenton Karl
Director
113,276$0113,276
(Direct)
View
2022-06-15
Option Award
2022-06-17
5:01 pm
N/A
2032-06-14
Iterum Therapeutics plcITRMAhrens Brenton Karl
Director
647,059$0647,059
(Direct)
View
2022-03-25
Option Award
2022-03-29
8:00 pm
N/A
2032-03-26
Iterum Therapeutics plcITRMAhrens Brenton Karl
Director
47,436$047,436
(Direct)
View
2021-06-23
Option Award
2021-06-25
4:05 pm
N/A
2031-06-22
Iterum Therapeutics plcITRMAhrens Brenton Karl
Director
64,706$064,706
(Direct)
View
2020-01-21
Option Award
2020-01-23
5:00 pm
N/A
2025-01-31
Iterum Therapeutics plcITRMAhrens Brenton Karl
Director
2,000,000$2,000,0002,000,000
(Indirect)
View